Finally, hope for a young patient
That night in the fall of 2009 was a new low in the course of Brenden’s disease, a rare immune disorder called chronic granulomatous disease, or CGD. The condition affects a key component of the immune system, a type of white blood cell called a neutrophil that engulfs and kills invading bacteria and fungi.
Since his diagnosis as a baby, Brenden had taken regular preventive antibiotics to fight off infections before they started, gotten thrice-weekly interferon shots to boost his weakened immune system, and avoided activities that might bring him into contact with troublesome microbes. Despite that care, he’d been hospitalized repeatedly for surgeries to drain abscesses and for intravenous antibiotics to fight infections.
Read more about Gene therapy trial at Boston Children’s that shows promise against devastating immune disorder>>